The UK neural implants market is expected to exhibit a rapid CAGR of 7.8% during the forecast period (2021-2027). In the UK, it is estimated that approximately 10–40% of individuals undergoing back surgery suffer from FBS. An estimated prevalence of FBS for neuropathic back and leg pain was around 5,800 per 100,000 population in the country. As a result, the NHS recommends such patients to undergo SCS procedures for effective treatment outcomes associated with chronic pain. Further, the recent guidelines in the UK from the National Institute for Health and Care Excellence (NICE) recommend the use of DBS for the treatment of PD.
To Request a Sample of our Report on UK Neural Implants Market: https://www.omrglobal.com/request-sample/uk-neural-implants-market
Additionally, owing to such a large patient pool, the market penetration of advanced medical devices such as neural implants is high in the UK. Further, the high penetration of such advanced medical devices paves a significant market opportunity for the global as well as regional players. As a result, vendors are coming up with new marketing and sales strategies to increase sales of highly advanced neural implants. Therefore, the high patient pool, coupled with the availability of advanced devices, is expected to boost the neural implants market in the UK.
Market Coverage
- Market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
- Segment Covered- by Product, Application, and End-user
- Country Covered- India
- Competitive Landscape- Abbott, Boston Scientific Corporation, LivaNova PLC, Medtronic, and Renishaw plc
(Get 15% Discount on Buying this Report)
A full Report of UK Neural Implants Market is Available at: https://www.omrglobal.com/industry-reports/uk-neural-implants-market
UK Neural Implants Market Report Segment
By Product
- Deep Brain Stimulation (DCS)
- Spinal Cord Stimulation (SCS)
- Vagus Nerve Stimulation (VNS)
By Application
- Chronic Pain
- Epilepsy
- Parkinson’s Disease (PD)
- Others (Depression and Other Movement Disorders)
By End-user
- Hospitals
- Outpatient Surgery Centers
- Specialized Neurological Centers (SNCs)
This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
